Abstract
Background
Although growing evidence links beta-amyloid (Aβ) and neuronal hyperexcitability in preclinical mouse models of Alzheimer’s disease (AD), a similar association in humans is yet to be established. The first aim of the study was to determine the association between elevated Aβ (Aβ+) and cognitive processes measured by the P3 event-related potential (ERP) in cognitively normal (CN) older adults. The second aim was to compare the event-related power between CNAβ+ and CNAβ−.
Methods
Seventeen CNAβ+ participants (age: 73 ± 5, 11 females, Montreal Cognitive Assessment [MoCA] score 26 ± 2) and 17 CNAβ- participants group-matched for age, sex, and MOCA completed a working memory task (n-back with n = 0, 1, 2) test while wearing a 256-channel electro-encephalography net. P3 peak amplitude and latency of the target, nontarget and task difference effect (nontarget−target), and event-related power in the delta, theta, alpha, and beta bands, extracted from Fz, Cz, and Pz, were compared between groups using linear mixed models. P3 amplitude of the task difference effect at Fz and event-related power in the delta band were considered main outcomes. Correlations of mean Aβ standard uptake value ratios (SUVR) using positron emission tomography with P3 amplitude and latency of the task difference effect were analyzed using Pearson Correlation Coefficient r.
Results
The P3 peak amplitude of the task difference effect at Fz was lower in the CNAβ+ group (P = 0.048). Similarly, power was lower in the delta band for nontargets at Fz in the CNAβ+ participants (P = 0.04). The CNAβ+ participants also demonstrated higher theta and alpha power in channels at Cz and Pz, but no changes in P3 ERP. Strong correlations were found between the mean Aβ SUVR and the latency of the 1-back (r = − 0.69; P = 0.003) and 2-back (r = − 0.69; P = 0.004) of the task difference effect at channel Fz in the CNAβ+ group.
Conclusions
Our data suggest that the elevated amyloid in cognitively normal older adults is associated with neuronal hyperexcitability. The decreased P3 task difference likely reflects early impairments in working memory processes. Further research is warranted to determine the validity of ERP in predicting clinical, neurobiological, and functional manifestations of AD.
Similar content being viewed by others
Introduction
Alzheimer’s disease (AD) is increasingly viewed as a disconnection syndrome leading to reduced communication between brain areas [1, 2]. Emerging evidence shows that the reduced neurotransmission is caused by the disturbance of the synaptic excitation/inhibition balance in the brain [1, 2]. Even in the preclinical phase when no cognitive impairments are apparent [3], beta-amyloid (Aβ) oligomers and Aβ plaques show associations with this excitation/inhibition imbalance and altered activity of local neuronal circuits and large-scale networks [4]. Preclinical mouse models of AD support the notion that this imbalance causes hyperactivity in hippocampal and cortical neurons and reductions of slow-wave oscillations, even before the appearance of Aβ plaques [4]. Such hyperactivity shifts the normal excitation/inhibition balance towards neuronal hyperexcitability, mediated through both increased excitation of synaptic glutamatergic tone and decreased GABAergic inhibition [4]. This relative neuronal hyperexcitability in turn leads to excitotoxicity [5] and amplification of synaptic release of Aβ [6], ultimately leading to further neurodegeneration and neuronal silencing mediated by concomitant tau accumulation [7]. Previous studies have explained this hyperexcitability as a physiological compensation for the increased Aβ burden in preclinical AD [8,9,10,11], wherein the accumulation of Aβ deposits results in neural recruitment, up until a certain threshold when the compensatory mechanisms fail. The hyperexcitability is then followed by hypoexcitability due to functional neuronal silencing in clinically diagnosed AD [7].
Electro-encephalography (EEG) offers insights into the postsynaptic activity of pyramidal cells and may therefore be useful for evaluating the impact of Aβ deposits on neuronal excitability in older adults across the spectrum of AD [12]. A systematic review of published studies has shown consistent evidence of hypoexcitability in AD, expressed as reduced power in the high-frequency bands, and lower amplitude and larger latency of event-related potentials (ERP) [12]. The associations between Aβ and neuronal excitability in mild cognitive impairment (MCI) and preclinical AD are less clear. One resting-state EEG study including older adults with subjective memory impairments has found a non-linear relationship between Aβ and delta power, in those individuals who showed signs of neurodegeneration, but not in those with normal-appearing brain [11]. Another study has shown that older adults with increased Aβ load and subjective cognitive impairments exhibit greater connectivity in the alpha band and reduced connectivity in the beta band [13]. Studies evaluating excitability under cognitive load in the cognitively normal (CN) older adults are even more limited. In a previous study, the event-related spectral power in the alpha and beta bands extracted while doing a working memory task (2-back) was higher in older adults with unknown Aβ status who showed deterioration in an 18-month follow-up assessment compared to CN participants who remained stable [14]. Although previous work suggests neuronal hyperexcitability in preclinical AD, possible changes in the event-related power in cognitively normal, amyloid elevated (CNAβ+) older adults are yet to be established.
Previous research suggests that the changes in spectral frequency due to increased amyloid burden reflect initial compensatory processes to maintain normal cognitive function [8, 9, 11]. However, it is unclear how neuronal hyperexcitability affects the efficiency of cognitive processing. ERPs offer unique insights into the neural processes of working memory under cognitive load. The P3 (or P300) is a positive ERP that appears at around 300 ms after stimulus onset. The amplitude of P3 is generally considered as a measure of resource allocation, particularly during working memory tests [15]. Higher cognitive demands result in decreased P3 amplitudes and longer latencies [16]. The attenuated P3 amplitude with increased cognitive demand is explained by the reallocation of resources away from the stimulus discrimination task towards processes that are more responsible for the higher demands posed on working memory, such as information storage and updating [17]. The P3 component can be isolated by discriminating the frequent nontarget from the infrequent target. This task difference effect reflects frontal lobe activity that is sensitive to the attentional demands induced by the task [18]. Larger task difference effects reflect more efficient discrimination ability in the stimulus evaluation process.
The main aim of this study was to compare the physiological response during working memory tasks of incremental cognitive demand between CN older adults with and without increased Aβ load. We hypothesized that CNAβ+ participants would show decreased P3 amplitude of the task difference effect compared to CN non-elevated (CNAβ−) participants. In a previous study [19], we established the reliability of the P3 ERP of the task difference effect at Fz in older adults with and without cognitive impairments. Therefore, we predesignated the P3 amplitude of the task difference effect at channel Fz as the main outcome variable, but also calculated the amplitude and latency of nontarget and target responses at channel Fz and additional midline channels Cz and Pz. The second aim of this study was to compare the event-related power between CNAβ+ and CNAβ− participants. Due to the early breakdown of slow-wave frequency bands shown in animals with preclinical AD [4], we expect lower event-related power in the delta band in CNAβ+. Since hypoexcitability in clinically diagnosed AD manifests as decreased power in the higher frequency bands, we expect increased power in the alpha and beta bands to reflect hyperexcitability in CNAβ+. Finally, we explored the association between Aβ uptake and P3 peak amplitude and latency of the task difference effect.
Materials and methods
Participants
All participants were recruited from the University of Kansas Alzheimer’s Disease Center between May 30, 2018 and July 20, 2020. Participants were excluded if they (1) were currently taking steroids, benzodiazepines, or neuroleptics; (2) had a history of any substance abuse; (3) had a history of a neurological disorder; or (4) had any contra-indications to positron emission tomography (PET) or EEG. The inclusion criteria were (1) age of 65 years or older; (2) understanding all instructions in English; (3) having given informed consent; and (4) a previously administered amyloid PET scan of the brain. The cerebral amyloid burden was assessed using PET images, obtained on a GE Discovery ST-16 PET/CT scanner after administration of intravenous Florbetapir 18F-AV45 (370 MBq) following a previously published protocol [20]. To determine the Aβ status, three experienced raters interpreted all PET images independently and without reference to any clinical information, as previously described [21]. The final status was determined by the majority of raters as Aβ− versus Aβ+, using a process that combined both visual and quantitative information [22, 23]. The median (Q1–Q3) time between the PET scan and EEG assessment was 1111 (794–1675) days.
Procedure
Demographic and clinical information
We recorded information of age, sex, education, race, and ethnicity of participants. The participants also completed the Montreal Cognitive Assessment (MoCA) as a general screen of cognitive functions, which was carried out by a member of the research team who was blinded to the group allocation [24]. Normal cognition was confirmed after a clinical assessment performed at the time around PET scan at the University of Kansas Alzheimer’s Disease Center, which included the Clinical Dementia Rating [25] and Uniform Data Set Neuropsychological Battery [26]. All participants reported to be right-hand dominant.
N-back test
In the n-back test, EEG was recorded while the participants were shown with a series of letters and instructed to press a button if the current stimulus was the same as the item presented n positions back (Fig. 1). The cognitive load increases with increased number, but the perceptual and motor demands remain the same. In this study, the 0-back, 1-back, and 2-back tests were administered (Fig. 1). The 0-back test was used as the control condition [27, 28]. The 1-back test requires the participant to passively store and update information in working memory. The 2-back test requires constant switching from the focus of attention to short-term memory [27]. Higher levels of difficulty require continuous mental effort to update information of new stimuli while maintaining representations of recently presented stimuli [29].
During the test, participants sat in a comfortable chair at 26 inches in front of a computer screen with the center of the screen at eye level. White letters appeared on the black screen. Participants completed a practice trial of 3 targets and 7 nontargets prior to each test. These practice sessions were repeated until the participants felt comfortable with the instructions. The actual test consisted of 60 trials that required a response by pressing the left mouse button (target, 33.3%) with their right index finger and 120 trials for which a response was not required (nontarget, 66.7%). Each letter was presented for 500 ms on the computer screen followed by a blank interstimulus interval for 1700 ms, with a random jitter of ± 50 ms. The allowed maximum response time was 2150 ms. The total task time was about 400 s. The number of correct responses (accuracy) and response times in the correct response trials were taken as the main behavioral outcome measures.
P3 ERP and event-related power
Continuous EEG was acquired using a Magstim EGI high-density system from 256 scalp electrodes, digitized at 1000 Hz. Data were online referenced to Cz and filtered using a 30 Hz low-pass filter and a 0.5 Hz high-pass filter in the EGI software. Although Kappenman and Luck recommend 0.10 Hz as the high-pass filter for EEG systems in P3 ERP studies [30], we used 0.5 Hz to account for the minimum high-pass filter threshold of 0.3 Hz set by the EGI system and to minimize the roll-off effect. All other EEG processing was done in EEGLab [31] and in ERPLab [32]. Recordings from electrodes around the face were first removed, leaving 183 electrode channels in the processing pipeline. Bad channels were removed through automatic identification and visual inspection of the EEG data. Various artifacts unrelated to cognitive functions, including ocular and muscular movement or cardiovascular signals, were identified and removed using independent component analysis. The stimulus-locked ERPs were extracted from the n-back tests and segmented into epochs of 100 ms before to 1000 ms after the stimulus onset, and baseline-corrected using the prestimulus interval. Epochs of incorrect and missed responses were removed from the analyses. Signals from bad electrodes were then interpolated using surrounding electrode data. Scalp locations and measurement windows for the P3 component were determined based on their spatial extent and latency after inspection of grand average waveforms. P3 peak amplitude of the task difference effect was considered the main outcome variable. The task difference effect was calculated by subtracting the average ERP elicited by targets from the average ERP elicited by nontargets (nontarget—target) for each participant. We also calculated P3 peak latency of the task difference effect as well as P3 peak amplitude and latency of the targets and nontargets. The P3-component time-window was established between 250 and 650 ms for all three tests. The average event-related power was identified in four frequency bands: delta [2–4 Hz], theta [4–8 Hz], alpha [8–12 Hz] and beta [12–30 Hz] [33]. Because of the involvement of prefrontal cortex in working memory, we analyzed P3 ERP from Fz, but also from Cz and Pz sites. Cz was interpolated using the surrounding five channels after re-referencing offline to the linked mastoids. No participants were excluded from analyses due to artifacts.
Data analysis
Descriptive analysis including mean (standard deviation), median (Q1–Q3), and frequency count of participants’ general demographics, performance measures, and ERP data was performed as appropriate. Unpaired t-tests, Median tests, and Chi-square tests were used to compare descriptive variables and performance in cognitive tests. We conducted linear mixed models to determine the effect of Aβ on P3 and event-related power at channel Fz. We used a random intercept term with a subject-specific coefficient to adjust for correlation between measures within subjects. Group (CNAβ+ and CNAβ−) and n-back difficulty (0, 1, 2) were entered as main effects. Interaction effects of group × n-back were also examined. Bonferroni correction was applied for pairwise comparisons. Residual analysis was used to validate model assumptions. Variables were transformed to their log function when residuals were not normally distributed. We entered age, sex, education, and MOCA as potential covariates in a separate linear mixed model. These analyses were repeated for channels Cz and Pz. In addition, linear mixed models were employed to investigate the main effects of group and condition (n-back) on the average event-related power in the delta, theta, alpha, and beta bands, and on performance in the n-back tests (response time and accuracy). Correlations of the mean Aβ standard uptake value ratio (SUVR) and the SUVR of six predefined regions (anterior cingulate, posterior cingulate, precuneus, inferior medial frontal, lateral temporal, and superior parietal cortex) with the P3 peak amplitude and latency of the task difference (nontarget—target) in each n-back test at channels Fz, Cz, and Pz were analyzed with Pearson r correlation coefficient. P < 0.05 was considered significant. Analyses were performed using SAS 9.4 and SAS Enterprise Guide 8.2 softwares.
Results
Participant characteristics
We recruited 17 CNAβ+ (age: 73 ± 5 years; 11 (65%) females; MOCA: 26 ± 2) and 17 CNAβ− (age: 75 ± 6; 12 (71%) females; MOCA: 28 ± 2) participants. MOCA scores ranged between 25 and 30. In the CNAβ+ group, two participants scored below 26 on the MOCA (22 and 23), and one participant was African American. All others identified their race as White. Two participants identified their ethnicity as Hispanic or Latino. No differences were observed for age, sex, and MOCA score between groups (Table 1).
We first analyzed differences in the accuracy and response time in the n-back test (Table 1). The linear mixed models showed no main group effects on response time (P = 0.36) and accuracy (P = 0.91).
P3 grand average waveforms
The grand average peak P3 amplitudes of the task difference effect (nontarget—target) of the two groups for each n-back condition at channels Fz, Cz, and Pz are shown in Additional file 1: Table S1. Figure 2 shows that the task difference effect of the peak amplitude at channel Fz was lower in CNAβ+ compared to CNAβ− (P = 0.048, P = 0.05 after adjusting for age, sex, and MoCA scores). No other effects were found for peak amplitude. Additional file 1: Table S2 shows that the P3 latency of the task difference effect at channel Fz was sensitive to changes in cognitive demand (non-adjusted P = 0.047; adjusted P = 0.05).
The grand average waveforms of the targets and nontargets at channel Fz of both groups are depicted in Fig. 3. Linear mixed model analysis revealed shorter P3 latency for nontargets (non-adjusted P = 0.006; adjusted P = 0.006) at channel Fz in CNAβ+ (Additional file 1: Table S2).
Grand average waveforms with P3 peak scalp maps of the target and nontarget responses for the three n-back tests between CNAβ+ (top) and CNAβ− (bottom) at channel Fz. Behavioral response times are indicated by the computer mouse. The 3D scalp maps are facing down and most of the P3 effects (red color) are distributed in the frontal area
No other effects were found at channels Cz and Pz, except for the peak latency of the nontargets at channel Cz that produced significant group effects (non-adjusted P = 0.04; adjusted P = 0.04).
P3 event-related power
Power in each of the frequency bands for each of the three n-back conditions at channels Fz, Cz, and Pz is detailed in Additional file 1: Table S3.
At channel Fz, the CNAβ+ participants exhibited lower power in the delta band for nontargets (unadjusted P = 0.04; adjusted P = 0.08, with age [P = 0.01] and MOCA scores [P = 0.007] contributing significantly to the model), compared to the CNAβ− participants.
At channel Cz, the CNAβ+ participants exhibited higher power in the theta band for the task difference effect (unadjusted P = 0.05; adjusted P = 0.09). In addition, higher power was observed in the alpha band for nontargets (unadjusted P = 0.05; adjusted P = 0.03), targets (unadjusted P = 0.04; adjusted P = 0.03), and the task difference effect (unadjusted P = 0.03; adjusted P = 0.09, with age [ P = 0.02] contributing significantly to the model).
At channel Pz, the CNAβ+ participants exhibited higher power in the theta band for nontargets (unadjusted P = 0.05; adjusted P = 0.07) and task difference effect (unadjusted P = 0.03; adjusted P = 0.11). Likewise, higher power in the alpha band was observed in the CNAβ+ group (unadjusted P = 0.03; adjusted P = 0.03).
Analyses of the beta band did not show significant effects.
Correlation between amyloid and P3 ERP
The correlation table shows stronger correlation of SUVR with ERP latency than with amplitude of the task difference effect (Fig. 4). Absolute Pearson r correlation coefficient of 0.53 and higher indicates significant correlation (P < 0.05). The mean Aβ SUVR of the CNAβ+ group correlated negatively with the P3 peak latency in the 1-back (r = − 0.69; P = 0.003) and 2-back (r = − 0.69; P = 0.004) tests at Fz. Aβ SUVR in the anterior cingulate cortex (r = − 0.74; P = 0.009), inferior medial frontal lobe (r = − 0.74; P = 0.001), posterior cingulate cortex (r = − 0.72; P = 0.002) and precuneus (r = − 0.64; P = 0.005) correlated strongly with the P3 peak latency in the 1-back test at channel Fz. Similarly, strong correlations were observed between Aβ SUVR in the posterior cingulate cortex (− 0.84; P = 0.0001), precuneus (r = − 0.68; P = 0.005), inferior medial frontal lobe (r = -0.59; P = 0.02), superior parietal lobe (r = − 0.59; P = 0.02), anterior cingulate cortex (r = − 0.56; P = 0.03), and lateral temporal lobe (r = − 0.54; P = 0.04) and the P3 peak latency in the 2-back test at channel Fz. Overall, the magnitude of correlations between Aβ SUVR and P3 peak amplitude and latency was smaller at channels Cz and Pz than at Fz in CNAβ+.
Pearson r correlations between beta-amyloid (Aβ) standard uptake value ratio and P3 event-related potential latency and amplitude for each n-back test at channel Fz, Cz, and Pz. The color heat map shows the magnitude of the correlations in the positive (green) and negative (red) direction. Bolded values are significant (P < 0.05). Top panel a shows correlations for the cognitively normal, elevated (CNAβ+) group; bottom panel b shows the correlations for the cognitively normal, non-elevated (CNAβ−) group
Aβ SUVR also correlated with the P3 peak amplitude of several n-back conditions in the CNAβ− group (Fig. 3b). SUVR in the superior parietal cortex correlated negatively with P3 peak amplitude of the 0-back test at channel Fz (r = − 0.69; P = 0.007) and of the 1-back test at channel Cz (r = − 0.69; P = 0.006). SUVR of the posterior cingulate cortex correlated with P3 peak amplitude of the 1-back test at Pz (r = − 0.58; P = 0.03). The mean SUVR correlated with P3 peak latency of the 2-back test at Fz (r = − 0.56; P = 0.04) and Cz (r = − 0.62; P = 0.01) and of the 1-back test at Pz (r = − 0.69; P = 0.006). Similar magnitudes of correlation were observed for subregions anterior cingulate cortex, inferior medial frontal lobe, posterior cingulate cortex, and precuneus.
Discussion
The goal of this study was to compare neuronal excitability during working memory of incremental cognitive demand between CNAβ+ and CNAβ− older adults. We demonstrated differences in the P3 ERP (decreased peak P3 ERP of the task difference) as well as changes in the event-related power (lower power in the low-frequency bands [delta] and higher power in the mid-range-frequency bands [theta, alpha]) in CNAβ+ adults, compared with CNAβ−. Cognitive load was not associated with the differences in P3 ERP amplitude between the two groups. In addition, we found strong correlations between Aβ deposits in cortical brain regions and P3 ERP. These findings point towards evidence of hyperexcitability in CNAβ+. However, this hyperexcitability did not appear to affect behavioral performance as no differences were found in accuracy and response times on the n-back test.
Our study demonstrated lower delta event-related power in the frontal midline channel, along with an increase in theta and alpha event-related power in the central and parietal midline channels in CNAβ+. These results confirm the preclinical AD animal model studies showing that hyperexcitability is related to early breakdown of low-frequency waves [4]. The increased event-related power in alpha and theta frequencies in CNAβ+ contrasts the changes in event-related power found in older adults with cognitive impairments. While an increase has been found in absolute theta power [34,35,36], the event-related theta power was significantly lower in response to cognitive load in MCI and AD compared to controls, reflecting hypoexcitability [36]. The combined lower event-related delta power and higher event-related alpha and theta power suggest that CNAβ+ older adults may exhibit neuronal hyperexcitability. A previous study investigating resting-state spectral power has classified CN older adults with subjective memory complaints according to their Aβ burden (+ or −) and associated neurodegeneration (+ or −) into four respective categories, and found a U-shaped distribution in delta power and an inverse U-shaped distribution in gamma power, most pronounced in CN individuals with signs of neurodegeneration [11]. In addition, the presence of neurodegeneration is associated with a decrease in lower-frequency waves (delta) and an increase in higher-frequency waves (beta and gamma) in the fronto-central regions [11]. Yet, there are no associations between Aβ load and spectral power in the absence of neurodegeneration.
The similarities in spectral power in the different frequency bands between the previous study [11] and ours imply that our group of CNAβ+ participants may have shown early signs of neurodegeneration. However, we cannot confirm this assumption as we did not formally assess neurodegeneration. Another potential explanation is that changes in power may appear earlier in the disease process (i.e., in Aβ+ with no neurodegeneration) under cognitive load as opposed to the resting state. Although no interaction effects of group by n-back were found, visual inspection of the P3 waveforms showed that the differences between CNAβ+ and CNAβ− were most obvious under highest cognitive load. However, our study may have been underpowered to elicit these differences statistically.
Although older adults with elevated amyloid may exhibit neuronal hyperexcitability, these compensatory processes do not result in more efficient neural processes. Our results showed that the CNAβ+ group exhibited a smaller P3 amplitude of the task difference effect, suggesting less efficient stimulus processing compared to CNAβ−. The absence of a clear effect of task difficulty on P3 amplitude and latency in the 2-back test in elevated amyloid also implies a lack of appropriate reallocation of cognitive resources away from stimulus evaluation. These findings, along with the non-significant differences in behavioral outcomes, suggest that the hyperexcitability is a non-functional compensation on neural level due to increased Aβ deposition, and may result in less efficient cognitive processing of working memory.
Our results suggest a direct link between average and regional Aβ burden and electrophysiological activity, particularly in the frontal cortex in CNAβ+. This is consistent with animal studies that found hyperactive neurons exclusively around the Aβ plaques [5], suggesting that Aβ exerts toxic effects on surrounding neurons and synapses, thereby disturbing their function and perhaps leading to dementia [37]. In particular, soluble Aβ oligomers have been shown to affect neuronal excitability in animal models and in vitro in humans [38]. However, no causal inferences can be made from our results. Longitudinal studies are required to identify the effect of Aβ burden on the relative postsynaptic excitation, and the role of P3 as a biomarker of pathophysiological, clinical, and functional decline. Future studies should investigate whether a relative increase in excitatory neurotransmitters, particularly glutamate, drives the link between Aβ burden and P3 ERP in preclinical AD. If confirmed, EEG metrics may be used as endpoints for mechanistic studies evaluating hypotheses related to autophagy [39], mitophagy [40], and selective neuronal vulnerability of AD [41], and for translational intervention studies aiming to reduce Aβ burden with pharmacological treatment [42], behavioral interventions (e.g., exercise), etc. [43]
Limitations of this study include the relatively small sample size and the long interval between PET scan and EEG testing. We cannot rule out the possibility that some CNAβ− participants might have converted to CNAβ+. The projected conversion rate from Aβ− to Aβ+ is about 4% per year [44], showing stability of cortical Aβ in the vast majority of older adults. However, we plan to conduct a future study where the PET scan and EEG assessment are conducted close in time. In addition, two participants in the CNAβ+ group scored below 26 on MoCA, which may indicate a change in cognitive status since their comprehensive cognitive assessment. Therefore, our results should be interpreted with caution. We also corrected for multiplicity by design. To account for the multiplicity, we designated in advance of the study a single linear mixed model with the task difference effect of P3 ERP as our primary result. All other tests were designated as secondary and presented in full to provide complete transparency. However, we did implement standard multiplicity adjustments within our linear mixed models. We chose the n-back test to test our hypotheses as working memory is regarded a core cognitive function sensitive to aging and early neurodegeneration, upon which higher-order cognitive skills, such as attention, decision making, and planning are built [45]. Our results are therefore unique to working memory and cannot be generalized to other domains of cognitive functions that are relevant to AD.
Conclusion
Older adults with normal cognition and elevated Aβ show neuronal hyperexcitability under cognitive load. This hyperexcitability affects cognitive processes indexed by the P3 ERP. Future studies are required to elucidate the causal effects between Aβ depositions and neural excitability.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- Aβ:
-
Beta-amyloid
- AD:
-
Alzheimer’s disease
- CN:
-
Cognitively normal
- EEG:
-
Electro-encephalography
- MCI:
-
Mild cognitive impairment
- MoCA:
-
Montreal Cognitive Assessment
- ERP:
-
Event-related potential
- ISI:
-
Interstimulus interval
- PET:
-
Positron emission tomography
- SUVR:
-
Standard uptake value ratio
References
Brier MR, Thomas JB, Ances BM. Network dysfunction in Alzheimer’s Disease: refining the disconnection hypothesis. Brain Connect. 2014;4(5):299–311.
Delbeuck X, Van der Linden M, Collette F. Alzheimer’s disease as a disconnection syndrome? Neuropsychol Rev. 2003;13(2):79–92.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer Dement. 2011;7(3):280–92.
Busche MA, Konnerth A. Impairments of neural circuit function in Alzheimer’s disease. Philos Trans R Soc Lond B Biol Sci. 2016;371(1700):20150429.
Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science. 2008;321(5896):1686–9.
Palop JJ, Mucke L. Amyloid-β–induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat Neurosci. 2010;13(7):812–8.
Toniolo S, Sen A, Husain M. Modulation of brain hyperexcitability: potential new therapeutic approaches in Alzheimer’s disease. Int J Mol Sci. 2020;21(23):9318.
Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, et al. Tau, amyloid, and cascading network failure across the Alzheimer’s disease spectrum. Cortex. 2017;97:143–59.
Lim HK, Nebes R, Snitz B, Cohen A, Mathis C, Price J, et al. Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects. Brain. 2014;137(12):3327–38.
Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, et al. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014;71(11):1379.
Gaubert S, Raimondo F, Houot M, Corsi MC, Naccache L, Diego Sitt J, et al. EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease. Brain. 2019;142(7):2096–112.
Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, et al. What electrophysiology tells us about Alzheimer’s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging. 2020;85:58–73.
Teipel S, Bakardjian H, Gonzalez-Escamilla G, Cavedo E, Weschke S, Dyrba M, et al. No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints. Neuroimage. 2018;17:435–43.
Deiber MP, Meziane HB, Hasler R, Rodriguez C, Toma S, Ackermann M, et al. Attention and working memory-related eeg markers of subtle cognitive deterioration in healthy elderly individuals. J Alzheimers Dis. 2015;47(2):335–49.
Isreal JB, Chesney GL, Wickens CD, Donchin E. P300 and tracking difficulty: evidence for multiple resources in dual-task performance. Psychophysiology. 1980;17(3):259–73.
Gevins A, Smith ME, Le J, Leong H, Bennett J, Martin N, et al. High resolution evoked potential imaging of the cortical dynamics of human working memory. Electroencephalogr Clin Neurophysiol. 1996;98(4):327–48.
Lubitz AF, Niedeggen M, Feser M. Aging and working memory performance: electrophysiological correlates of high and low performing elderly. Neuropsychologia. 2017;106:42–51.
Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol. 2007;118(10):2128–48.
Devos H, Burns JM, Liao K, Ahmadnezhad P, Mahnken JD, Brooks WM, et al. Reliability of P3 event-related potential during working memory across the spectrum of cognitive aging. Front Aging Neurosci. 2020;12:566391.
Vidoni ED, Morris JK, Watts A, Perry M, Clutton J, Van Sciver A, et al. Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer’s: a 1-year randomized controlled trial. PLoS One. 2021;16(1):e0244893.
Harn NR, Hunt SL, Hill J, Vidoni E, Perry M, Burns JM. Augmenting amyloid PET interpretations with quantitative information improves consistency of early amyloid detection. Clin Nucl Med. 2017;42(8):577–81.
Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol. 2012;11(8):669–78.
Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, et al. Performance characteristics of amyloid PET with Florbetapir F18 in patients with Alzheimer’s disease and cognitively normal subjects. J Nucl Med. 2012;53(3):378–84.
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–4.
Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, et al. Version 3 of the Alzheimer Disease Centers’ neuropsychological test battery in the uniform data set (UDS). Alzheimer Dis Assoc Disord. 2018;32(1):10–7.
Bopp KL, Verhaeghen P. Aging and n-back performance: a meta-analysis. J Gerontol B Psychol Sci Soc Sci. 2020;75(2):229–40.
Miller KM, Price CC, Okun MS, Montijo H, Bowers D. Is the n-back task a valid neuropsychological measure for assessing working memory? Arch Clin Neuropsychol. 2009;24(7):711–7.
Gevins A, Smith ME, McEvoy LK, Ilan AB, Chan CS, Jiang A, et al. A cognitive and neurophysiological test of change from an individual’s baseline. Clin Neurophysiol. 2011;122(1):114–20.
Kappenman ES, Luck SJ. The effects of electrode impedance on data quality and statistical significance in ERP recordings. Psychophysiology. 2010;47(5):888–904.
Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004;134(1):9–21.
Lopez-Calderon J, Luck SJ. ERPLAB: an open-source toolbox for the analysis of event-related potentials. Front Hum Neurosci. 2014;8:213.
Possti D, Fahoum F, Sosnik R, Giladi N, Hausdorff JM, Mirelman A, et al. Changes in the EEG spectral power during dual-task walking with aging and Parkinson’s disease: initial findings using Event-Related Spectral Perturbation analysis. J Neurol. 2021;268(1):161–8.
Jiang ZY. Study on EEG power and coherence in patients with mild cognitive impairment during working memory task. J Zhejiang Univ Sci B. 2005;6(12):1213–9.
Grunwald M, Busse F, Hensel A, Riedel-Heller S, Kruggel F, Arendt T, et al. Theta-power differences in patients with mild cognitive impairment under rest condition and during haptic tasks. Alzheimer Dis Assoc Disord. 2002;16(1):40–8.
Goodman MS, Zomorrodi R, Kumar S, Barr MS, Daskalakis ZJ, Blumberger DM, et al. Changes in theta but not alpha modulation are associated with impairment in working memory in Alzheimer’s disease and mild cognitive impairment. J Alzheimer Dis. 2019;68:1085–94.
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6.
Hector A, Brouillette J. Hyperactivity induced by soluble amyloid-β oligomers in the early stages of Alzheimer's disease. Front Mol Neurosci. 2021;13(244).
Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, et al. Autophagy in healthy aging and disease. Nat Aging. 2021;1(8):634–50.
Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci. 2019;22(3):401–12.
Fu H, Hardy J, Duff KE. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1350–8.
Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M. Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval. Alzheimer Res Ther. 2020;12(1).
Vasconcelos-Filho FSL, Da Rocha Oliveira LC, De Freitas TBC, De Pontes PADS, Da Rocha-E-Silva RC, Chaves EMC, et al. Neuroprotective mechanisms of chronic physical exercise via reduction of β-amyloid protein in experimental models of Alzheimer's disease: a systematic review. Life Sci. 2021;275:119372.
Jagust WJ, Landau SM, Initiative ftAsDN. Temporal dynamics of β-amyloid accumulation in aging and Alzheimer disease. Neurology. 2021;96(9):e1347–e1357.
Baddeley A. Working memory. Science. 1992;255(5044):556–9.
Acknowledgements
This work was completed at the Hoglund Biomedical Imaging Center which is supported by the Forrest and Sally Hoglund and a High-End Instrumentation grant from the National Institutes of Health (S10 RR29577).
Funding
Research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number K01 AG058785. This study was supported in part by a pilot grant of the KU Alzheimer Disease Center (P30 AG035982). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
HD, KG, WB, JM, and JB conceptualized the study. HD, KL, and PA administered the EEG assessments. HD, KG, and KL created the pipeline for EEG processing. HD and BE processed the EEG data. HD and JM created the statistical plan and conducted the statistical analyses. HD, KG, KL, WB, JM, JB, PA, LM, and BE interpreted the results. HD wrote the first version of the manuscript. KG, KL, WB, JM, JB, PA, LM, and BE reviewed and revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was approved by the Human Subjects Committee of the University of Kansas Medical Center (#4461). Informed consent was obtained from all participants.
Competing interests
The authors declare that they have no competing interests.
Consent to publication
Not applicable.
Supplementary Information
Additional file 1
: Table S1. P3 peak amplitude and latency at Fz/Cz/Pz across testing conditions of CNAβ+ and CNAβ−. Table S2. Event-related power (µV/Hz2) at Fz/Cz/Pz, across testing conditions of CNAβ+ and CNAβ− (Mean ± SD). Table S3. Event-related power (μV/Hz2) of CNAβ+ (n = 17) and CNAβ− (n = 17) at Fz/Cz/Pz, across testing conditions (Mean ± SD).
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Devos, H., Gustafson, K., Liao, K. et al. EEG/ERP evidence of possible hyperexcitability in older adults with elevated beta-amyloid. Transl Neurodegener 11, 8 (2022). https://doi.org/10.1186/s40035-022-00282-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40035-022-00282-5